Randomized, placebo-controlled, double-blind, phase II study of axitinib plus docetaxel versus docetaxel plus placebo in patients with metastatic breast cancer

  1. Rugo, H.S.
  2. Stopeck, A.T.
  3. Joy, A.A.
  4. Chan, S.
  5. Verma, S.
  6. Lluch, A.
  7. Liau, K.F.
  8. Kim, S.
  9. Bycott, P.
  10. Rosbrook, B.
  11. Bair, A.H.
  12. Soulieres, D.
Aldizkaria:
Journal of Clinical Oncology

ISSN: 0732-183X,  1527-7755

Argitalpen urtea: 2011

Alea: 29

Zenbakia: 18

Orrialdeak: 2459-2465

Mota: Artikulua

DOI: 10.1200/JCO.2010.31.2975 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus